PRLR, His, Mouse
Prolactin receptor (PRLR) is highly expressed in a subset of human breast cancer and prostate cancer, which makes it a potential target for cancer treatment. In clinical trials, the blockade of PRLR was shown to be safe but with poor efficacy. It is therefore urgent to develop new therapies against PRLR target. Bispecific antibodies (BsAbs) could guide immune cells toward tumor cells, and produced remarkable effects in some cancers.
| ¥3000 在线订购包邮(港澳台除外) | |
| Z06320-100 | |
|
|
|
|
|
|
|
|
|
| 咨询产品问题 | |